Jochen Maurer Selected Research

QC6352

11/2017

KDM4 Inhibition Targets Breast Cancer Stem-like Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jochen Maurer Research Topics

Disease

17	Neoplasms (Cancer) 01/2022 - 11/2010
5	Triple Negative Breast Neoplasms 01/2022 - 12/2016
5	Neoplasm Metastasis (Metastasis) 10/2020 - 07/2011
5	Breast Neoplasms (Breast Cancer) 01/2020 - 12/2016
2	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 07/2011
1	Bites and Stings (Sting) 10/2021
1	Ovarian Neoplasms (Ovarian Cancer) 10/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2020
1	Uterine Cervical Dysplasia 12/2020
1	Urinary Bladder Neoplasms (Bladder Cancer) 10/2020
1	Adenocarcinoma 01/2019
1	Tics (Tic) 01/2019
1	Osteolysis 02/2017
1	Carcinogenesis 11/2010

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 01/2022 - 11/2017
3	Proteins (Proteins, Gene)FDA Link 05/2017 - 01/2011
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 10/2021
2	MicroRNAs (MicroRNA)IBA 12/2020 - 01/2020
2	Peptide Hydrolases (Proteases)FDA Link 01/2019 - 01/2019
2	Lysine (L-Lysine)FDA Link 01/2019 - 11/2017
2	Small Interfering RNA (siRNA)IBA 01/2019 - 11/2010
2	Conditioned Culture MediaIBA 01/2019 - 02/2017
2	Metalloproteases (Metalloproteinases)IBA 01/2019 - 01/2019
2	Zinc Finger E-box-Binding Homeobox 1IBA 05/2017 - 12/2015
2	Phenobarbital (Luminal)FDA Link 12/2016 - 01/2013
1	Electron Transport Complex I (NADH-CoQ Reductase)IBA 01/2022
1	UbiquinoneIBA 01/2022
1	CytokinesIBA 10/2021
1	niraparibIBA 10/2021
1	Antineoplastic Agents (Antineoplastics)IBA 10/2021
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2021
1	B7-H1 AntigenIBA 10/2021
1	Messenger RNA (mRNA)IBA 01/2020
1	Estrogens (Estrogen)FDA Link 01/2020
1	human ERBB2 proteinIBA 01/2020
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2020
1	DisintegrinsIBA 01/2019
1	Histones (Histone)IBA 01/2019
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 01/2019
1	enzalutamideIBA 01/2019
1	Androgen Receptors (Androgen Receptor)IBA 01/2019
1	AndrogensIBA 01/2019
1	Hormones (Hormone)IBA 01/2018
1	QC6352IBA 11/2017
1	Cadherins (E-Cadherin)IBA 05/2017
1	Transcription Factors (Transcription Factor)IBA 02/2017
1	Proteoglycans (Proteoglycan)IBA 02/2017
1	Indicators and Reagents (Reagents)IBA 02/2017
1	Hyaluronic Acid (Hyaluronan)IBA 02/2017
1	staurosporine aglycone (K252a)IBA 12/2016
1	Phosphotransferases (Kinase)IBA 12/2016
1	Protein Isoforms (Isoforms)IBA 12/2015
1	rho-Associated KinasesIBA 01/2013
1	Monoclonal AntibodiesIBA 07/2011
1	VimentinIBA 07/2011
1	Green Fluorescent ProteinsIBA 11/2010

Therapy/Procedure

8	Therapeutics 01/2022 - 11/2017
2	Neoadjuvant Therapy 01/2018 - 11/2017
1	Immunotherapy 10/2021
1	Precision Medicine 10/2020
1	Drug Therapy (Chemotherapy) 01/2020
1	Castration 01/2019
1	Immunomodulation 01/2018
1	Transplantation 11/2010